Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2002
Volume 26
Issue 10

The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.

Recent Videos
Leroy Hood, MD, PhD
Jens Schmidt, associate director MSAT at Lonza
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content